- About
- Projects
- Column 1
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Food & Nutrition
- Column 2
- Column 1
- News and Events
- Expanded Access eRequest
FDA Provides Update on External Evaluation to Strengthen Agency’s Human Foods Program -FDA Statement
In July, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Human Foods Program, including the Office of Food Policy and Response (OFPR), the Center for Food Safety and Applied Nutrition (CFSAN), as well as relevant parts of the Office of Regulatory Affairs (ORA).
FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program - FDA Statement
Earlier this year, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Tobacco Program, to be conducted by an external expert panel facilitated by the Reagan-Udall Foundation, led by former FDA Chief of Staff Lauren Silvis. The panel was asked to assess the Tobacco Program’s regulatory processes and agency operations relating to regulations and guidance, application review, compliance and enforcement and communication with the public and other stakeholders.
RAISE: Collecting Better Data: Incentives, Framework, and Mission
RAISE: Collecting Better Data: Incentives, Framework, and Mission
Thursday, February 2, 2023
2-3 PM ET
Incomplete and inconsistent capture of information about race and ethnicity in real-world data (RWD) limits a full understanding of the distribution, safety, and effectiveness of FDA-regulated products, which impacts the health of the public.
FDA needs a new approach to e-cigarettes and other safer alternatives to traditional cigarettes - The Reason Foundation
Last month, the Reagan-Udall Foundation delivered a damning review of the Food and Drug Administration’s (FDA) performance as a tobacco regulator.
Understanding Fatal Overdoses to Inform Product Development and Public Health Interventions to Manage Overdose
Understanding Fatal Overdoses to Inform Product Development and
Public Health Interventions to Manage Overdose
March 8, 1-4:45 PM ET
March 9, 1-4:45 PM ET
The Reagan-Udall Foundation for the FDA, in partnership with the U.S. Food and Drug Administration (FDA), hosted a virtual public meeting on March 8-9, to explore the evolving context surrounding fatal overdoses.
Q&A with FDA Commissioner Robert Califf on baby formula, food safety - The Washington Post
The baby formula crisis of 2022 triggered intense soul-searching at the U.S. Food and Drug Administration. What went wrong? How can the government prevent similar disasters from happening again?